by Five Rivers Rx | Mar 11, 2021 | Industry News, Regulations
When initially signed by President Obama in 2013, industry was well aware of the sweeping changes it would cause in the supply chain. With full implementation officially less than three years away, industry has taken huge strides in the implementation of the law – and...
by Five Rivers Rx | Feb 4, 2021 | Drug Manufacturers, Regulations
Legislators set the rules, and regulators enforce them – and if either side doesn’t pull their weight, it leads to glaring issues which can disrupt the supply chain. A common practice for state regulators is to look to each other for support in the rulemaking process...
by Five Rivers Rx | Jan 7, 2021 | DEA
In November 2020, the Drug Enforcement Administration (DEA) issued a Notice of Proposed Rulemaking (NPRM) proposing to revise its regulations relating to suspicious orders of controlled substances. The proposed rules will clarify requirements to process a suspicious...
by Five Rivers Rx | Dec 17, 2020 | Industry News
Last month, Iowa became the second of five states to formally recognize/approve the NCDQS QAS Accreditation program, and the first state to approve the program by rule, revising Iowa Code section 17A.8(6). The Maryland Board of Pharmacy approved the NCDQS QAS...
by Five Rivers Rx | Nov 19, 2020 | NavigateSOM, Suspicious Order Monitoring
NavigateSOM is excited to announce the release of our User Manual. Our goal is to walk clients through step by step how to most effectively utilize every feature in their portal, giving them the most value. It begins with gaining access to your portal and some helpful...
